Equillium to Present at Investor Conferences in November 2019

LA JOLLA, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, today announced that Bruce Steel, Equillium?s president and chief business officer, will present at two upcoming investor conferences in November 2019.